Clostridium difficile Infection Epidemiology
Dec 16, 2022
Evaluating the Potential of Emerging Therapies for Recurrent Clostridium Difficile Infection (rCDI)
Clostridium difficile Infection (CDI), one of the most common nosocomial and community-acquired infections globally, is a major public health challenge. The Clostridium difficile bacteria are a toxin-producing pathogen that produces two types of toxins: toxin A (an enterotoxin) and toxin B (a cytotoxin). This toxin...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
